ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Moberg Pharma AB (publ): cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
129.974M{"amount": 129974000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- Moberg Pharma AB (publ)
- Metric
- cashflow_financing
- Period
- 2021-01-01 – 2021-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:549300XFXK7DVGDRP410:2022-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T00:47:10.733722+02:00
Raw response SHA-256
3f1a369d9f83a057226817a5a4dff3da…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.